down arrow

Chenguang Biotech Group Co., Ltd.

  • Market Cap: Small Cap
  • Industry: FMCG
  • ISIN: CNE100000WC5
CNY
12.10
-0.28 (-2.26%)

Dec 04

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Chenguang Biotech Group Co., Ltd.
Why is Chenguang Biotech Group Co., Ltd. ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
  • Poor long term growth as Net Sales has grown by an annual rate of 15.51% and Operating profit at -5.33% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
  • The company has been able to generate a Return on Equity (avg) of 10.89% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 15.51% and Operating profit at -5.33% over the last 5 years
3
The company has declared positive results in Mar'2025 after 5 consecutive negative quarters
  • RAW MATERIAL COST(Y) Fallen by -104.15% (YoY)
  • CASH AND EQV(HY) Highest at CNY 5,351.05 MM
  • OPERATING PROFIT(Q) Highest at CNY 133.4 MM
4
With ROE of 6.20%, it has a fair valuation with a 1.58 Price to Book Value
  • Over the past year, while the stock has generated a return of 37.74%, its profits have fallen by -25.5%
  • At the current price, the company has a high dividend yield of 1.3
5
Market Beating Performance
  • The stock has generated a return of 37.74% in the last 1 year, much higher than market (China Shanghai Composite) returns of 15.18%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Chenguang Biotech Group Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to FMCG should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in FMCG)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Chenguang Biotech Group Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Chenguang Biotech Group Co., Ltd.
32.24%
1.37
39.72%
China Shanghai Composite
14.77%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
15.51%
EBIT Growth (5y)
-5.33%
EBIT to Interest (avg)
4.66
Debt to EBITDA (avg)
4.87
Net Debt to Equity (avg)
0.90
Sales to Capital Employed (avg)
0.89
Tax Ratio
20.28%
Dividend Payout Ratio
71.51%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.79%
ROE (avg)
10.89%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
25
Industry P/E
Price to Book Value
1.58
EV to EBIT
27.50
EV to EBITDA
15.81
EV to Capital Employed
1.42
EV to Sales
0.89
PEG Ratio
NA
Dividend Yield
1.35%
ROCE (Latest)
5.17%
ROE (Latest)
6.20%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -104.15% (YoY

CASH AND EQV(HY)

Highest at CNY 5,351.05 MM

OPERATING PROFIT(Q)

Highest at CNY 133.4 MM

OPERATING PROFIT MARGIN(Q)

Highest at 7.8 %

PRE-TAX PROFIT(Q)

Highest at CNY 120.39 MM

NET PROFIT(Q)

Highest at CNY 108.43 MM

EPS(Q)

Highest at CNY 0.23

-17What is not working for the Company
NET PROFIT(9M)

At CNY 101.31 MM has Grown at -58.86%

DEBT-EQUITY RATIO (HY)

Highest at 89.62 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.91%

DEBTORS TURNOVER RATIO(HY)

Lowest at 14.84%

NET SALES(Q)

Lowest at CNY 1,709.45 MM

INTEREST(Q)

Highest at CNY 33.85 MM

Here's what is working for Chenguang Biotech Group Co., Ltd.
Pre-Tax Profit
At CNY 120.39 MM has Grown at 365.53%
over average net sales of the previous four periods of CNY 25.86 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit
At CNY 108.43 MM has Grown at 380.26%
over average net sales of the previous four periods of CNY 22.58 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (CNY MM)

Operating Profit
Highest at CNY 133.4 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Operating Profit Margin
Highest at 7.8 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at CNY 120.39 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit
Highest at CNY 108.43 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS
Highest at CNY 0.23
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Cash and Eqv
Highest at CNY 5,351.05 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost
Fallen by -104.15% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Chenguang Biotech Group Co., Ltd.
Interest
At CNY 33.85 MM has Grown at 10.69%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Sales
Lowest at CNY 1,709.45 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Interest
Highest at CNY 33.85 MM
in the last five periods and Increased by 10.69% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debt-Equity Ratio
Highest at 89.62 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio
Lowest at 1.91%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio
Lowest at 14.84%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."